Key Takeaways
- • Frazier Healthcare Partners, a Seattle-based private equity firm, has closed a $490 million acquisition of MatrixCare, a software company previously owned by ResMed, in an all-cash transaction.
- • MatrixCare is a healthcare software platform, and the acquisition represents Frazier's continued focus on investing in healthcare technology and software solutions across the midmarket sector.
- • The deal closure reflects Frazier Healthcare Partners' strategic positioning in healthcare IT, aligning with the firm's track record of raising substantial capital ($11+ billion globally under management) for healthcare-focused buyout funds.
- • Jonathan Lujan has been appointed Chief Executive Officer of MatrixCare following the acquisition completion, signaling management continuity and fresh leadership direction post-acquisition.
- • The transaction demonstrates ongoing capital deployment in the healthcare software space, where ResMed divested a non-core business unit to focus on other priorities.
Summary
Frazier Healthcare Partners, the Seattle-based private equity firm founded in 1991 and led by Managing Partner Nader Naini, has successfully completed its $490 million acquisition of MatrixCare from ResMed. The transaction was executed on an all-cash basis, according to multiple sources covering the deal closure dated September 2, 2026.
MatrixCare is a software company serving the healthcare sector, and its acquisition by Frazier represents a strategic deployment of capital into healthcare technology—a core focus area for the firm. The deal involved ResMed, a San Diego-based healthcare technology company, divesting the MatrixCare business as part of its broader portfolio management strategy. Frazier Healthcare Partners has established itself as a leading healthcare-focused private equity investor, having raised more than $11 billion in institutional capital globally and managing multiple buyout funds targeting the healthcare middle market.
Following the acquisition completion, Frazier appointed Jonathan Lujan as Chief Executive Officer of MatrixCare, establishing continuity and new strategic direction for the software platform under private equity ownership. This leadership appointment underscores Frazier's hands-on approach to portfolio company management and value creation in the healthcare IT sector.
The transaction aligns with Frazier's recent fundraising momentum, including the closure of its $2.3 billion 11th Growth Buyout Fund and demonstrates the firm's continued capacity to deploy capital into healthcare software and technology businesses. The $490 million MatrixCare acquisition reflects both the market's valuation of healthcare software assets and Frazier's confidence in the business as a platform for growth within its healthcare investment portfolio.
MatrixCare is a software company serving the healthcare sector, and its acquisition by Frazier represents a strategic deployment of capital into healthcare technology—a core focus area for the firm. The deal involved ResMed, a San Diego-based healthcare technology company, divesting the MatrixCare business as part of its broader portfolio management strategy. Frazier Healthcare Partners has established itself as a leading healthcare-focused private equity investor, having raised more than $11 billion in institutional capital globally and managing multiple buyout funds targeting the healthcare middle market.
Following the acquisition completion, Frazier appointed Jonathan Lujan as Chief Executive Officer of MatrixCare, establishing continuity and new strategic direction for the software platform under private equity ownership. This leadership appointment underscores Frazier's hands-on approach to portfolio company management and value creation in the healthcare IT sector.
The transaction aligns with Frazier's recent fundraising momentum, including the closure of its $2.3 billion 11th Growth Buyout Fund and demonstrates the firm's continued capacity to deploy capital into healthcare software and technology businesses. The $490 million MatrixCare acquisition reflects both the market's valuation of healthcare software assets and Frazier's confidence in the business as a platform for growth within its healthcare investment portfolio.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.